Cargando…

Drug synergy discovery of tavaborole and aminoglycosides against Escherichia coli using high throughput screening

High incidences of urinary tract infection (UTI) of aminoglycosides-resistant E.coli causes a severe burden for public health. A new therapeutic strategy to ease this crisis is to repurpose non-antibacterial compounds to increase aminoglycosides sensibility against multidrug resistant E.coli pathoge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shasha, She, Pengfei, Li, Zehao, Li, Yimin, Li, Linhui, Yang, Yifan, Zhou, Linying, Wu, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715904/ https://www.ncbi.nlm.nih.gov/pubmed/36454354 http://dx.doi.org/10.1186/s13568-022-01488-6

Ejemplares similares

Identification of a small molecule 0390 as a potent antimicrobial agent to combat antibiotic-resistant Escherichia coli
por: Li, Linhui, et al.
Publicado: (2022)

Pixantrone Sensitizes Gram-Negative Pathogens to Rifampin
por: She, Pengfei, et al.
Publicado: (2022)

Insights into the antimicrobial effects of ceritinib against Staphylococcus aureus in vitro and in vivo by cell membrane disruption
por: Liu, Shasha, et al.
Publicado: (2022)

Repurposing 9-Aminoacridine as an Adjuvant Enhances the Antimicrobial Effects of Rifampin against Multidrug-Resistant Klebsiella pneumoniae
por: She, Pengfei, et al.
Publicado: (2023)

Spotlight on tavaborole for the treatment of onychomycosis
por: Jinna, Sphoorthi, et al.
Publicado: (2015)

An upcoming drug for onychomycosis: Tavaborole
por: Sharma, Neha, et al.
Publicado: (2015)

Synergy between Florfenicol and Aminoglycosides against Multidrug-Resistant Escherichia coli Isolates from Livestock
por: Kim, Shukho, et al.
Publicado: (2020)

armA and Aminoglycoside Resistance in Escherichia coli
por: González-Zorn, Bruno, et al.
Publicado: (2005)

Repurposing Eltrombopag as an Antimicrobial Agent Against Methicillin-Resistant Staphylococcus aureus
por: She, Pengfei, et al.
Publicado: (2022)

Genetic Basis of Persister Tolerance to Aminoglycosides in Escherichia coli
por: Shan, Yue, et al.
Publicado: (2015)

Bioenergetic State of Escherichia coli Controls Aminoglycoside Susceptibility
por: El Khoury, Jessica Y., et al.
Publicado: (2023)

Population-based inference of aminoglycoside resistance mechanisms in Escherichia coli
por: Mancini, Stefano, et al.
Publicado: (2019)

A qnr-plasmid allows aminoglycosides to induce SOS in Escherichia coli
por: Babosan, Anamaria, et al.
Publicado: (2022)

Fungicidal Activity in the Presence of Keratin as an Important Factor Contributing to In Vivo Efficacy: A Comparison of Efinaconazole, Tavaborole, and Ciclopirox
por: Tachibana, Haruki, et al.
Publicado: (2017)

Antimicrobial Synergy between Aminoglycosides and Licorice Extract in Listeria monocytogenes
por: Park, Myungseo, et al.
Publicado: (2022)

SPR741, Double- or Triple-Combined With Erythromycin and Clarithromycin, Combats Drug-Resistant Klebsiella pneumoniae, Its Biofilms, and Persister Cells
por: She, Pengfei, et al.
Publicado: (2022)

Antibiotic synergist OM19r reverses aminoglycoside resistance in multidrug-resistant Escherichia coli
por: Cui, Qi, et al.
Publicado: (2023)

Ciprofloxacin, amoxicillin, and aminoglycosides stimulate genetic and phenotypic changes in uropathogenic Escherichia coli strains
por: Adamus-Białek, Wioletta, et al.
Publicado: (2019)

High-Throughput Identification of Antibacterials Against Pseudomonas aeruginosa
por: Li, Shijia, et al.
Publicado: (2020)

Mechanism of Synergy Between Tetracycline and Quercetin Against Antibiotic Resistant Escherichia coli
por: Qu, Shaoqi, et al.
Publicado: (2019)

Antimicrobial, Antibiofilm, and Anti-persister Activities of Penfluridol Against Staphylococcus aureus
por: Liu, Yaqian, et al.
Publicado: (2021)

Lantana montevidensis Briq improves the aminoglycoside activity against multiresistant Escherichia coli and Staphylococcus aureus
por: Sousa, Erlanio O., et al.
Publicado: (2011)

Proton motive force underpins respiration-mediated potentiation of aminoglycoside lethality in pathogenic Escherichia coli
por: Webster, Calum M., et al.
Publicado: (2022)

High Throughput Screen for Escherichia coli Twin Arginine Translocation (Tat) Inhibitors
por: Bageshwar, Umesh K., et al.
Publicado: (2016)

Chaperonin GroEL/GroES Over-Expression Promotes Aminoglycoside Resistance and Reduces Drug Susceptibilities in Escherichia coli Following Exposure to Sublethal Aminoglycoside Doses
por: Goltermann, Lise, et al.
Publicado: (2016)

Robustness analysis of culturing perturbations on Escherichia coli colony biofilm beta-lactam and aminoglycoside antibiotic tolerance
por: Zuroff, Trevor R, et al.
Publicado: (2010)

Escherichia coli SPFH Membrane Microdomain Proteins HflKC Contribute to Aminoglycoside and Oxidative Stress Tolerance
por: Wessel, Aimee K., et al.
Publicado: (2023)

Aminoglycoside riboswitch control of the expression of integron associated aminoglycoside resistance adenyltransferases
por: Zhang, Jun, et al.
Publicado: (2020)

The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia
por: Alyamani, Essam J., et al.
Publicado: (2017)

Parallel Evolution of High-Level Aminoglycoside Resistance in Escherichia coli Under Low and High Mutation Supply Rates
por: Ibacache-Quiroga, Claudia, et al.
Publicado: (2018)

Beta-lactam, aminoglycoside, and quinolone resistance in Escherichia coli strains isolated from shrimps and mussels in the Marmara Sea
por: Celik, Baran, et al.
Publicado: (2023)

High-Throughput Screening of a Promoter Library Reveals New Persister Mechanisms in Escherichia Coli
por: Mohiuddin, Sayed Golam, et al.
Publicado: (2022)

High-Throughput Screening for Biomarker Discovery
por: Janvilisri, Tavan, et al.
Publicado: (2015)

The Outer Membrane Proteins and Their Synergy Triggered the Protective Effects against Pathogenic Escherichia coli
por: Pen, Guihong, et al.
Publicado: (2022)

Nitric oxide (NO) elicits aminoglycoside tolerance in Escherichia coli but antibiotic resistance gene carriage and NO sensitivity have not co-evolved
por: Ribeiro, Cláudia A., et al.
Publicado: (2021)

Analysis of Compound Synergy in High-Throughput Cellular Screens by Population-Based Lifetime Modeling
por: Peifer, Martin, et al.
Publicado: (2010)

High-Throughput Screening of Biodiversity for Antibiotic Discovery
por: Terekhov, S. S., et al.
Publicado: (2018)

Evolving the l-lysine high-producing strain of Escherichia coli using a newly developed high-throughput screening method
por: Wang, Yan, et al.
Publicado: (2016)

Antibiotic stress-induced modulation of the endoribonucleolytic activity of RNase III and RNase G confers resistance to aminoglycoside antibiotics in Escherichia coli
por: Song, Wooseok, et al.
Publicado: (2014)

Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae
por: Han, Seung Beom, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fc55hgbofho5nunc3gd0rgc9oi